Antimalarial drugs chloroquine and hydroxychloroquine could find another use as cancer treatments, according to a new clinical study published in ecancermedicalscience.
Nov 23, 2017
0
4
(HealthDay)—Malaria drugs touted by some as potential "game changers" against COVID-19 are actually too dangerous for general use, the U.S. Food and Drug Administration warned Americans on Friday.
Apr 27, 2020
0
5
Hydroxychloroquine can be ruled out as a treatment for hospitalised COVID-19 patients—but the World Health Organization said Thursday it was aware of ongoing trials into its value as a preventative measure.
Jun 18, 2020
0
1
(HealthDay)—For adults hospitalized with COVID-19, dexamethasone and remdesivir use increased over time, although dexamethasone is still somewhat underused, according to a study published online Aug. 17 in the Annals of ...
Aug 17, 2021
0
34
(HealthDay)—The number of adverse drug reactions (ADRs) associated with hydroxychloroquine and chloroquine more than doubled in 2020 compared with 2018 and 2019, according to a research letter published online Jan. 26 in ...
Jan 27, 2021
0
3
University of Minnesota Medical School physician researchers studied hydroxychloroquine as a treatment to prevent COVID-19 for those with high-risk for exposure to the virus—health care workers.
Oct 22, 2020
0
2
(HealthDay)—From February to March 2020, there was a considerable increase in the number of patients receiving outpatient prescriptions for hydroxychloroquine, chloroquine, and azithromycin, according to a research letter ...
Jul 8, 2020
0
2
(HealthDay)—Despite numerous studies suggesting that certain drugs touted by President Donald Trump as "game changers" against coronavirus are actually useless and even harmful, Trump on Monday claimed he has been taking ...
May 19, 2020
1
1
The heightened awareness around the anti-malaria drug hydroxychloroquine as well as other experimental treatments for COVID-19 has led to reports of risky behaviors, according to Yale School of Medicine physicians.
Apr 2, 2020
0
10
New research shows that adults with lupus who take the antimalarial drug, hydroxychloroquine, do not have any differences in their corrected QT (QTc) intervals, an electrocardiogram (EKG) measurement of the heart's electrical ...
Nov 6, 2020
1
5
